Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | STAT3 | P40763 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GRM1 | Q13255 | 4/20 | 0.54 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8645151 | 0.82 | STAT3 (0.53) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL28160291 | 0.82 | STAT3 (0.53) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL3641269 | 0.82 | STAT3 (0.53) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL3633495 | 0.82 | ALDH1A1 (0.58) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL3640530 | 0.82 | KMT2A (0.65) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| Hydrochloric Acid SCHEMBL6991460 | 0.81 | KMT2A (0.62) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL24597657 | 0.80 | KDM4E (0.67) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL12014829 | 0.80 | PSMB5 (0.62) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL20043088 | 0.79 | STAT3 (0.50) | ALDH1A1HPGDSTAT3KDM4EGAA | |
| SCHEMBL13227169 | 0.79 | SMN1; SMN2 (0.55) | ALDH1A1HPGDSTAT3KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110128371-A | A kind of phenthazine benzaldehyde derivative and preparation method thereof, phenthazine quinoline fluorescence probe and its preparation method and application | 中国科学院上海微系统与信息技术研究所 | 2019-08-16 | — | — | CN | claimed |
| CN-120058625-A | Organic compound and application thereof in electronic device | 浙江光昊光电科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120058533-A | Organic compound and application thereof in organic electronic device | 浙江光昊光电科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119552184-A | Organic compound, mixture, composition, organic light-emitting device and display panel | TCL华星光电技术有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119409716-A | Organic compound, organic light-emitting device and display panel | 广州华睿光电材料有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119390718-A | Organic compound, organic light-emitting device and display panel | 广州华睿光电材料有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-119039331-A | Organic compound, mixture, composition, organic light-emitting device and display panel | 广州华睿光电材料有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-117693278-A | Composition, mixture, light-emitting element and display panel | 深圳市华星光电半导体显示技术有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117466755-A | Organic compound, composition, organic electroluminescent device and display panel | 深圳市华星光电半导体显示技术有限公司 | 2024-01-30 | — | — | CN | disclosed |
| US-11806409-B2 | Imaging methods using 18F-radiolabeled biologics | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230241258-A1 | IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS | BRISTOL-MYERS SQUIBB COMPANY | 2023-08-03 | — | — | US | disclosed |
| CN-111278834-B | Aromatic amine compound, polymer, composition and organic electronic device | 广州华睿光电材料有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-110128371-A | A kind of phenthazine benzaldehyde derivative and preparation method thereof, phenthazine quinoline fluorescence probe and its preparation method and application | 中国科学院上海微系统与信息技术研究所 | 2019-08-16 | — | — | CN | disclosed |
| US-20170258948-A1 | NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING | BRISTOL-MYERS SQUIBB COMPANY | 2017-09-14 | — | — | US | disclosed |
| US-8765757-B2 | 3-heterocyclic substituted indole derivatives and methods of use thereof | MERCK SHARP & DOHME CORP. (US) | 2014-07-01 | — | — | US | disclosed |
| EP-2261226-A1 | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-12-15 | — | — | EP | disclosed |
| EP-1485707-B1 | CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS | CAPROTEC BIOANALYTICS GMBH (DE) | 2009-01-14 | — | — | EP | disclosed |
| US-20070015758-A1 | Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230241258-A1 | IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS | FCGRT, FAP, FUCA1 | ALDH1A1 1702/4885HPGD 209/4885STAT3 2618/4885 |
| US-11806409-B2 | Imaging methods using 18F-radiolabeled biologics | FCGRT, FAP, FUCA1 | ALDH1A1 1702/4885HPGD 209/4885STAT3 2618/4885 |
| US-20070015758-A1 | Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors | CETP, NPC1, DBI | ALDH1A1 3986/4885HPGD 3328/4885STAT3 4632/4885 |
| US-20170258948-A1 | NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING | PDCD10, PDCD1LG2, CD274 | ALDH1A1 4371/4885HPGD 4222/4885STAT3 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.